StockData
ANI Pharmaceuticals Inc logo

ANI Pharmaceuticals Inc (ANIP) income statement

ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3046% below fair value
$71.47+1.48 (+2.11%)

Close on Nov 18, 2026Market cap $1.64BP/E 15.2Yield –

ANI Pharmaceuticals Inc income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
60.4%
Operating margin
15.4%
Net margin
11.1%
Return on equity, FY2025
16.6%

Financial strength

Current ratio
2.91
Debt to equity
0.50
Debt to assets
20.2%
Cash to current liabilities
127.0%

Valuation

P/E ratio
15.2
Price to sales
1.68
Price to book
2.75
Dividend yield
–

See a number that looks wrong?